Yantai Dongcheng to Acquire US Firm XingImaging for $30.2M
China-based Yantai Dongcheng Pharmaceutical Group Co., Ltd (SHE: 002675) is set to acquire a 100%...
Hotgen Biotech’s COVID-19 Antigen Home Test Approved in Russia
China-based Hotgen Biotech Co., Ltd (SHA: 688068) announced receiving market approval in Russia for its...
Angel Pharmaceuticals Presents CPI-818 Data at ASH 2022 Annual Meeting
China-based Angel Pharmaceuticals Ltd announced the latest results of the global Phase I/Ib clinical study...
ClinBrain and WCH Establish Joint Laboratory for Geriatric Information Platform
Shanghai-based ClinBrain, a clinical data repository (CDR) and medical big data services provider, together with...
Wuhan YZY Biopharma Files for IPO on Hong Kong Stock Exchange
China-based Wuhan YZY Biopharma Co., Ltd, a biopharmaceutical company focused on targeted cancer drugs and...
JW Therapeutics Presents Carteyva Data at ASH Annual Meeting
China-based JW Therapeutics (HKG: 2126) presented the latest clinical data on Carteyva (relmacabtagene autoleucel injection)...
4B Technologies Raises RMB 100M in Pre-Series B Financing Round
China-based 4B Technologies Investments Ltd, a biotech focused on central nervous system (CNS) drug development,...
Gaush Meditech IPOs on Hong Kong Stock Exchange at HKD 21.4 per Share
China-based Gaush Meditech Ltd reportedly made an initial public offering (IPO) at the Hong Kong...
Northeast Pharmaceutical Fined RMB 133M for Monopoly Selling
Northeast Pharmaceutical Co., Ltd (SHE: 000597) was fined RMB 133 million (USD 19m) by the...
Dizal Pharma Presents Golidocitinib Data at ASH Annual Meeting
China-based Dizal Pharmaceutical Co., Ltd (SHA: 688192) presented the latest clinical data on golidocitinib (DZD4205)...
HitGen and Nitrase Therapeutics Enter Research Agreement
China-based HitGen Inc. (SHA: 688222) announced a research agreement with US firm Nitrase Therapeutics, Inc....
Sequanta Technologies and Iomics Bio Collaborate on Multi-Omics Research
Sequanta Technologies, a multi-omics research and clinical service provider based in Shanghai, and Iomics Biosciences...
Innoforce Partners with RNAimmune for mRNA Development and Production
Hangzhou-based biopharma partner company Innoforce Pharmaceuticals Co., Ltd struck a partnership with RNAimmune, a spin-off...
NMPA Approves COVID-19 Antigen Detection Reagents from Four Companies
The National Medical Products Administration (NMPA) announced the marketing approvals for COVID-19 antigen detection reagents...
Biozon Partners with Agilent Technologies to Boost ICP-MS in China Clinics
Zhejiang-based third-party detection service company Biozon struck a partnership with US firm Agilent Technologies. The...
Sino Biopharmaceutical’s ATR Kinase Inhibitor TCC1727 Accepted for FDA Review
China-based Sino Biopharmaceutical Ltd (HKG: 1177) announced the acceptance for review of its Investigational New...
Acotec Scientific and Boston Scientific Enter Acquisition and Collaboration Agreement
China-based Acotec Scientific Holdings Ltd (HKG: 6669) and US major Boston Scientific Corporation (NYSE: BSX)...
Biogen’s Aducanumab Administered to Chinese Patient for First Time
US major Biogen’s (NASDAQ: BIIB) Alzheimer’s disease (AD) therapy aducanumab has been administered to a...
Stemirna Therapeutics’ COVID-19 mRNA Vaccine Gets EUA in Laos
Stemirna Therapeutics Co., Ltd, an mRNA drug developer based in Shanghai, has obtained Emergency Use...
Medbanks Set for IPO on Hong Kong Stock Exchange
Sipai Health Technology Co., Ltd, also known as Medbanks, is set to make an initial...